PharmiWeb.com - Global Pharma News & Resources
25-Jun-2019

Pharmacovigilance Market is expected to witness flourish CAGR of 13.45% and is projected to reach USD 9.3 billion by 2024

Global Pharmacovigilance Market is expected to witness flourish CAGR of 13.45% and is projected to reach USD 9.3 billion by 2024 from USD 3.8 billion in 2017.

The Global Pharmacovigilance Market studies the overall dynamics and trends of the market in terms of various segments and regional outlook for the period of 2018 to 2024. The report offers of historic and future market scenario in terms of market value, share and critical developments taking place in the industry. Market size, forecast, trends of each country and region are studied in the report for the focus period of 2018 to 2024.

We can provide sample pages for a better understanding of this report.
Request Sample of This Report @ http://www.amecoresearch.com/sample/12296

Qualitative assessment tools such as PEST analysis, cost structure analysis and regulatory compliance for pharmaceutical products are offered in the report. The report also comprises Pipeline Analysis which helps understand the comprehensive forecast scenario of the market in terms of value and dynamics. The report analyses the recent drug approval trends and market dynamics such as drivers, restrains, and opportunities, industry trends and future outlook in the Global Pharmacovigilance Market.

The report represents key players operating in the market along with its competitive landscape. The competitive landscape includes player positioning analysis, competitive matrix and market share analysis of the key players operating in the industry. The market attractive index highlights the most lucrative regional market to invest in the market.

The market is studied for regions such as North America (U.S., and Canada), Europe (U.K., Germany, France, Spain, and Rest of Europe), Asia Pacific (China, Japan, India, South Korea, Australia, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America) and Middle East amp; Africa (GCC, South Africa, and Rest of Middle East amp; Africa).

Key Takeaways:

What is the market size in 2018 and the growth rate of the Global Pharmacovigilance Market?

What is the market drivers, restrains, opportunities governing the Global Pharmacovigilance Market?

Which are the largest and the fastest growing segments in the Global Pharmacovigilance Market?

Who are the key players operating in the market and their market position?

What is the pipeline scenario, drug pricing analysis and technological development in the market?

View Detail Report With Complete Table Of Content@ http://www.amecoresearch.com/market-report/global-pharmacovigilance-market-emr-12296

The key factors propelling the growth of market includes increasing incidence of adverse drug reactions (ADRs) coupled with increase prevalence of acute and chronic disease, and rising consumption of drugs. Moreover, rising demand in end-use industry owing to new drug developments further impelling the market growth.

The years used for the assessment are as follows:

Historical year: 2014, 2015 and 2016

Base year: 2017

Forecast period: 2018 ndash; 2024

RESEARCH METHODOLOGY

The research and analysis is based on the data and information obtained from various primary and secondary sources. The data obtained is validated by interacting with the companies of the concerned domain. The steps involved in the research methodology are;

Obtaining historical data of the market based on news, articles, publications, annual reports, white papers, surveys, and other secondary sources
Interacting with key opinion leaders of the market and developing data points based on interaction with them
Study of past trends in the market and their year on year Impact on the market size and share
Analyzing the collected data points
Bridging the data points to calculate the total global pharmacovigilance market and its various segments
Anticipating potential risks
Analyzing market forces such as drivers, restraints, and opportunities to assess new growth areas for the global pharmacovigilance market
Finalizing the overall size and share of the global pharmacovigilance market

OBJECTIVES:

To analyze market trends, opportunities, drivers, and restraints associated with the global pharmacovigilance market
To study market response with respect to the mergers and acquisitions in the industry
To profile key companies operating in the global pharmacovigilance market and provide their competitive landscape

MARKET SCOPE

The research scope for global pharmacovigilance market is as follows:

By Clinical Trials

Preclinical Studies
Phase I Trials
Phase II Trials
Phase III Trials
Phase IV Trials

By Service

Contract Outsourcing
In-house

By Type of Method

Targeted Spontaneous Reporting
Cohort Event Monitoring
EHR Mining
Intensified ADR Reporting
Spontaneous Reporting

By End-use Industry

Pharmaceutical
Medical Device
Biotechnological

By Region

North America
Latin America
Europe
Asia-Pacific
Middle East and Africa

FREE ANALYSIS

The global pharmacovigilance market is expected to witness CAGR of 13.45% and is projected to reach USD 9,300 million by 2024 from USD 3,800 million in 2017. The key factors propelling the growth of market include increasing incidences of adverse drug reactions (ADRs), and rising demand in end-use industry owing to new drug developments.

Pharmacovigilance science and science relates to the use of detection, assessment, and understanding to prevent the adverse effects of drugs and drug-related problems. Pharmacovigilance also incorporates a drug development process used in the monitoring of the effects of drugs after they have been approved for use. Pharmacovigilance legislations are often upgraded to clarify the roles and responsibilities of various stakeholders, strengthening of the risk-adjusted approach, improvement of transparency, and strengthening and clarification of procedures in relation to the use of PASS and RMP. This ensures the growth of pharmacovigilance market over the forecast period.

North America held the largest revenue share of the global market, owing to large production of new drugs development, along with increasing number of clinical trials in the region has led to increase in growth of the market. Moreover, rising incidences of Adverse Drug Reaction (ADRs) contribute to more than 100,000 deaths in the United States annually and is one of the leading causes of deaths. Regulator bodies are developing active surveillance approaches to assess the risk of medicine in the post-market phase of the novel products.

Asia-Pacific is expected to be the fastest growing market, due to growing number of acute and chronic diseases and increasing drug safety concerns among healthcare professionals. Growing number of clinical trials being conducted in Asia-Pacific, especially in China and India have propelled the market growth in this region. Moreover, stringent government regulations to maintain pharmaceutical industryrsquo;s quality standards have given impetus to the market in this region.

Some of the key companies operating in the market include Laboratory Corporation of America Holdings, IBM Corporation, Capgemini, ICON plc, PAREXEL International Corporation, United BioSource Corporation, BioClinica, Wipro Ltd., Cognizant,Quintiles IMS Holdings, Inc., GlaxoSmithKline, Novartis International AG, and among others.

Table Of Contents

Global Pharmacovigilance Market Outlook, Trend and Opportunity Analysis, Competitive Insights, Actionable Segmentation amp; Forecast 2024

CHAPTER 1. Market Scope and Methodology

1.1. Research methodology

1.2. Research scope amp; assumptions

1.3. List of data sources

CHAPTER 2. Executive Summary

2.1. Pharmacovigilance ndash; Market Snapshot

CHAPTER 3. Industry Analysis

3.1. Market definition

3.2. Market segmentation

3.3. Key findings of the Global Pharmacovigilance Market

3.4. Market opportunities amp; trends

3.4.1. Market driver analysis

3.4.1.1. Involvement of International Health authority

3.4.1.2. Increasing awareness about drug safety issues

3.4.1.3. Increasing incidences of ADR(Adverse Drug Reactions) and drug toxicity

3.4.1.4. Growing number of research and development activities

3.4.2. Market restraint analysis

3.4.2.1. Lack of skilled labor

3.4.3. Industry Analysis-Porters five forces of analysis

CHAPTER 4. Competitive Outlook

4.1. Competitive analysis

4.2. Competitive factors

4.3. Strategies adopted

CHAPTER 5. Global Pharmacovigilance Market Size and Forecast (2014 ndash; 2024)

5.1. Global Pharmacovigilance Market, By Clinical Trials (USD Million)

5.1.1. Preclinical Studies

5.1.2. Phase I Trials

5.1.3. Phase II Trials

5.1.4. Phase III Trials

5.1.5. Phase IV Trials

5.2. Global Pharmacovigilance Market, By Service (USD Million)

5.2.1. Contract Outsourcing

5.2.2. In-house

5.3. Global Pharmacovigilance Market, By Type of Method (USD Million)

5.3.1. Targeted Spontaneous Reporting

5.3.2. Cohort Event Monitoring

5.3.3. EHR Mining

5.3.4. Intensified ADR Reporting

5.3.5. Spontaneous Reporting

5.4. Global Pharmacovigilance Market, By End-use Industry (USD Million)

5.4.1. Pharmaceutical

5.4.2. Medical Device

5.4.3. Biotechnological

CHAPTER 6. Global Pharmacovigilance Market Size and Forecast, By Geography (2014-2024)

6.1. North America Pharmacovigilance Market (USD Million)

6.1.1. North America Pharmacovigilance Market, By Clinical Trials (USD Million)

6.1.2. North America Pharmacovigilance Market, By Service (USD Million)

6.1.3. North America Pharmacovigilance Market, By Type of Method (USD Million)

6.1.4. North America Pharmacovigilance Market, By End-use Industry (USD Million)

6.1.5. North America Pharmacovigilance Market, By Country (USD Million)

6.1.5.1. United States

6.1.5.2. Canada

6.2. Latin America Pharmacovigilance Market

6.2.1. Latin America Pharmacovigilance Market, By Clinical Trials (USD Million)

6.2.2. Latin America Pharmacovigilance Market, By Service (USD Million)

6.2.3. Latin America Pharmacovigilance Market, By Type of Method (USD Million)

6.2.4. Latin America Pharmacovigilance Market, By End-use Industry (USD Million)

6.2.5. Latin America Pharmacovigilance Market, By Country (USD Million)

6.2.5.1. Mexico

6.2.5.2. Brazil

6.2.5.3. Rest of Latin America

6.3. Europe Pharmacovigilance Market

6.3.1. Europe Pharmacovigilance Market, By Clinical Trials (USD Million)

6.3.2. Europe Pharmacovigilance Market, By Service (USD Million)

6.3.3. Europe Pharmacovigilance Market, By Type of Method (USD Million)

6.3.4. Europe Pharmacovigilance Market, By End-use Industry (USD Million)

6.3.5. Europe Pharmacovigilance Market, By Country (USD Million)

6.3.5.1. Germany

6.3.5.2. France

6.3.5.3. United Kingdom

6.3.5.4. Italy

6.3.5.5. Russia

6.3.5.6. Rest of Europe

6.4. Asia-Pacific Pharmacovigilance Market

6.4.1. Asia-Pacific Pharmacovigilance Market, By Clinical Trials (USD Million)

6.4.2. Asia-Pacific Pharmacovigilance Market, By Service (USD Million)

6.4.3. Asia-Pacific Pharmacovigilance Market, By Type of Method (USD Million)

6.4.4. Asia-Pacific Pharmacovigilance Market, By End-use Industry (USD Million)

6.4.5. Asia-Pacific Pharmacovigilance Market, By Country (USD Million)

6.4.5.1. China

6.4.5.2. Australia

6.4.5.3. Japan

6.4.5.4. Singapore

6.4.5.5. India

6.4.5.6. New Zealand

6.4.5.7. Rest of Asia-Pacific

6.5. Middle East and Africa Pharmacovigilance Market

6.5.1. Middle East and Africa Pharmacovigilance Market, By Clinical Trials (USD Million)

6.5.2. Middle East and Africa Pharmacovigilance Market, By Service (USD Million)

6.5.3. Middle East and Africa Pharmacovigilance Market, By Type of Method (USD Million)

6.5.4. Middle East and Africa Pharmacovigilance Market, By End-use Industry (USD Million)

6.5.5. Middle East and Africa Pharmacovigilance Market, By Country

6.5.5.1. Saudi Arabia

6.5.5.2. UAE

6.5.5.3. Egypt

6.5.5.4. South Africa

6.5.5.5. Rest of Middle East and Africa

CHAPTER 7. Key Players and Strategic Developments

7.1. Laboratory Corporation of America Holdings

7.1.1. Business Overview

7.1.2. Product and Service Offering

7.1.3. Financial Overview

7.1.4. Strategic Developments

7.2. IBM Corporation

7.2.1. Business Overview

7.2.2. Product and Service Offering

7.2.3. Financial Overview

7.2.4. Strategic Developments

7.3. ICON plc.

7.3.1. Business Overview

7.3.2. Product and Service Offering

7.3.3. Financial Overview

7.3.4. Strategic Developments

7.4. PAREXEL International Corporation

7.4.1. Business Overview

7.4.2. Product and Service Offering

7.4.3. Financial Overview

7.4.4. Strategic Developments

7.5. United BioSource Corporation

7.5.1. Business Overview

7.5.2. Product and Service Offering

7.5.3. Financial Overview

7.5.4. Strategic Developments

7.6. BioClinica

7.6.1. Business Overview

7.6.2. Product and Service Offering

7.6.3. Financial Overview

7.6.4. Strategic Developments

7.7. Wipro Ltd.

7.7.1. Business Overview

7.7.2. Product and Service Offering

7.7.3. Financial Overview

7.7.4. Strategic Developments

7.8. Cognizant

7.8.1. Business Overview

7.8.2. Product and Service Offering

7.8.3. Financial Overview

7.8.4. Strategic Developments

7.9. Quintiles IMS Holdings, Inc.

7.9.1. Business Overview

7.9.2. Product and Service Offering

7.9.3. Financial Overview

7.9.4. Strategic Developments

7.10. GlaxoSmithKline

7.10.1. Business Overview

7.10.2. Product and Service Offering

7.10.3. Financial Overview

7.10.4. Strategic Developments

7.11. Novartis International AG

7.11.1. Business Overview

7.11.2. Product and Service Offering

7.11.3. Financial Overview

7.11.4. Strategic Developments

Quick Buy This Premium Report From Here: http://www.amecoresearch.com/buy/12296

About Us:

Ameco Research is the one spot destination for all your research needs. Ameco Research holds the repository of quality research reports from numerous publishers across the globe. Our inventory of research reports caters to various industry verticals including Healthcare, Information and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc. With the complete information about the publishers and the industries they cater to for developing market research reports, we help our clients in making purchase decision by understanding their requirements and suggesting best possible collection matching their needs.

Contact:

Email: sales@amecoresearch.com | +1 407 915 4157

Editor Details

Last Updated: 25-Jun-2019